Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2009
05/27/2009CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors)
05/27/2009CN100491370C Sulfamate benzothiophene ester derivatives as steroid sulfatase inhibitors
05/27/2009CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
05/27/2009CN100491366C Use of wogonin as medicament for treatment of anxiety
05/27/2009CN100491364C Sesquiterplactone in dandelion and its use of resisting Gram's positive bacteria
05/27/2009CN100491363C C7 ester-substituted taxane
05/27/2009CN100491362C Biologically active methylene blue derivatives
05/27/2009CN100491361C Thiazole derivatives and their use as VAP-1 inhibitors
05/27/2009CN100491360C Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
05/27/2009CN100491358C Pyrimidinone compounds, compositions and methods
05/27/2009CN100491357C Benzimidazole compound and its preparing method and use in medicine production
05/27/2009CN100491356C Compounds exhibiting thrombopoietin receptor agaonism
05/27/2009CN100491354C Quinoline kind iriyellowsin electronic isostere and its preparation process and use
05/27/2009CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
05/27/2009CN100491352C Asymmetrical cyclic diamine compound
05/27/2009CN100491349C Antiviral agent
05/27/2009CN100491348C Thrombosis resisting preparation
05/27/2009CN100491342C Crystalline beta2 adrenergic receptor agonist
05/27/2009CN100491336C Novel derivatives of 3,3-diphenylpropylamines
05/27/2009CN100491316C Novel compounds, their preparation and use
05/27/2009CN100490902C Photochemical internalization for virus-mediated molecule delivery into the cyosol
05/27/2009CN100490901C Tetramethylpyrazine derivatives modified silk fibroin protein fiber anti-coagulant material and its preparation method
05/27/2009CN100490899C Pharmaceutical compositions
05/27/2009CN100490897C Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
05/27/2009CN100490893C Osteogenic composition
05/27/2009CN100490887C Suppository and preparation thereof
05/27/2009CN100490877C Active extractive of Foliumnerviliae, preparation method and application
05/27/2009CN100490873C Medicinal composition for treating high fever and preparation method thereof
05/27/2009CN100490866C Ready prepared Chinese medicine for treating deep source nasal congestion
05/27/2009CN100490864C Yin-nourishing fatigue-relieving capsules
05/27/2009CN100490858C Chinese-western medicine composition containing azelaic acid for treating acne
05/27/2009CN100490853C Composition containing minocycline
05/27/2009CN100490851C Chinese-western medicine composition for treating acne
05/27/2009CN100490847C Medicine liquid for treating burns and scalds and its preparation
05/27/2009CN100490845C Herbal composition and its use in chemotheraphy
05/27/2009CN100490842C Headache treating medicine
05/27/2009CN100490841C Pharyngitis treating ointment
05/27/2009CN100490839C Chinese medicine preparation for curing cardio-cerebral vascular diseases
05/27/2009CN100490838C Medicinal active component of whiteflower wisteria root and its preparing process and quality control method
05/27/2009CN100490830C Composition with anti-oxidation and metabolism-promotion functions
05/27/2009CN100490828C Externally applied medicine for treating piles and its preparing process and quality detection method
05/27/2009CN100490824C Medicinal composition for treating blood vessel kind disease, its preparation process and its use
05/27/2009CN100490823C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
05/27/2009CN100490822C Gelatin for preventing conglutination in the surgical and the method for preparing the same
05/27/2009CN100490821C New use of tremella heteropolysaccharide or its extract
05/27/2009CN100490820C Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents
05/27/2009CN100490819C Medicines of different characters and their preparation and use
05/27/2009CN100490818C Methods for treating hepatitis delta virus infection with beta-L-2' deoxy-uncleosides
05/27/2009CN100490817C Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination
05/27/2009CN100490816C Azithromycin oral disintegration tablet and its preparing method
05/27/2009CN100490815C Cardiac and cerebral vascular disease treating medicinal composition
05/27/2009CN100490814C Voglibose dispersion tablet
05/27/2009CN100490813C Application of thiophosphorylation amino and its methyl in preparation of drug for relieving chronic pain
05/27/2009CN100490812C Compisition as substitution of phthalocyanine cooperator and low density lipoprotein and its preparation process
05/27/2009CN100490811C Piperazine derivative used as CCRS antagonist
05/27/2009CN100490810C Flashmelt oral dosage formulation
05/27/2009CN100490809C Tablet comprising cetirizine and pseudoephedrine
05/27/2009CN100490808C Gliquilone slow-releasing preparation
05/27/2009CN100490807C Cephalofruxin ester liposome, its preparation and medicinal composition containing it
05/27/2009CN100490806C Oral dispersion domperidone coutrolled-release gel and its preparing method
05/27/2009CN100490805C Composition for the transdermal delivery of fentanyl
05/27/2009CN100490804C Ophthalmological use of roflumilast for the treatment of diseases of the eye
05/27/2009CN100490803C Autoemulsified albendazole preparation and its preparation process
05/27/2009CN100490802C Injection use medicine composition containing water-soluble 17-allylamino-17-demethoxy geldanamycin
05/27/2009CN100490801C Ginkgolide B dropping pill and its preparing method
05/27/2009CN100490800C Pharmaceutical solution formulations containing 17-AAG
05/27/2009CN100490799C Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
05/27/2009CN100490798C Quick disintegrated tablet or oral cavity disintegrated tablet containing L-glutamic acid and azulene sodium sulfonate and making method thereof
05/27/2009CN100490797C Pharmaceutical compositions
05/27/2009CN100490796C Methodc for preparing sub-micron gemfibrozil medicament powder
05/27/2009CN100490795C Red sage root salvianolic acid A injection formulation for treating cardiovascular diseases and preparation process thereof
05/27/2009CN100490794C Lomustine liposome freeze-drying powder injection and its preparation method
05/27/2009CN100490793C Remedies for neurodegenerative diseases
05/27/2009CN100490792C Use of Teroo hydrochloride and its chemical analog in preparation of anti-liver fibrotic medicine
05/27/2009CN100490791C Compositions and methods to treat neovascularization and disease associated with thereof
05/27/2009CN100490790C Enteric coated omeprazole pellets capsule and the preparing method thereof
05/27/2009CN100490788C American ginseng vitamine soft capsule
05/27/2009CN100490786C Chinese traditional medicine preparation for treating heart disease and preparation method
05/27/2009CN100490782C Methanesulfonic acid pazufloxacin gel droplet for ear and its preparation
05/27/2009CN100490677C Nutritious tablet for female
05/26/2009US7538257 Fluid wound dressing comprising partially cured polyurethane
05/26/2009US7538249 Tolterodine, compositions and uses thereof, and preparation of the same
05/26/2009US7538246 Trifluoroacetate blocking of alanine amino group, friedel crafts reaction with methoxybenzene, reduction of carbonyl group, chlorosulphonation and deprotection; claimed tamsulosin intermediates; simplification
05/26/2009US7538238 Preparing oil/fat comprising triglycerides in which medium-chain fatty acids are bound to 1 and 3 positions and a polyunsaturated fatty acid is bound to the 2 position for use in foods, beverages and pharmaceutical agents; dietetics
05/26/2009US7538233 Nitric oxide synthetase inhibitor; central nervous system disorders; multiple sclerosis; brain disorders; Parkinson's, Alzheimer's, Huntington's disease; amyotropic lateral sclerosis; antidepressants; schizophrenia
05/26/2009US7538231 Tyrosine kinase inhibitors
05/26/2009US7538226 (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
05/26/2009US7538224 Such as 2,4-dihydroxy-6-(2-methoxyethyl)phenylphenylketone; antitumor activity; heat shock protein (Hsp) suppression
05/26/2009US7538221 Polymorphs of racemic, dextrorotatory, and levorotatory enantioners of 1-cyclopropyl-6-fluoro-8-methoxy-7-(4-amino-3,3-dimethylpiperidin-1-yl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid hydrochloride and mesylate salts
05/26/2009US7538220 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin
05/26/2009US7538216 Guanidino phenylalanin compounds used as urokinase inhibitors
05/26/2009US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4
05/26/2009US7538193 Using deoxy-S-nitrosohemoglobin and glutathione, cysteine and/or N-acetylcysteine to treat and prevent ischemic injury, hypertension, angina, reperfusion injury and inflammation
05/26/2009US7538141 N-benzyl-2-{3-[2-({2-hydroxy-2-[5-hydroxy-6-(hydroxymethyl)pyridin-2-yl]ethyl}amino)-2-methylpropyl]phenyl}acetamide; beta 2 adrenergic receptors agonist; antiinflammatory, antiallergent, respiratory system disorder; side effect reduction; pharmacokinetics, potency, selectivity, duration of action
05/26/2009US7538138 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders
05/26/2009US7538137 Nutraceutical; aqueous extract of Sibiraea leaves; obesity, lipid metabolism, hypoglycemic agent, hair growth, healthy food
05/26/2009US7538136 Crystalline forms of atorvastatin
05/26/2009US7538135 Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
05/26/2009US7538134 1-aryl-4-cyclopropylpyrazoles with at least one fluorine attached to the cyclopropyl ring; parasiticides; fleas; Extended duration of action for at least 28 days
05/26/2009US7538133 Benzimidazole derivatives, their production and use